Novel inhibitors of checkpoint kinase 1

被引：19

作者：

Arrington, Kenneth L.

Dudkin, Vadim Y.

机构：

来源：

CHEMMEDCHEM | 2007年 / 2卷 / 11期

关键词：

D O I：

10.1002/cmdc.200700131

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

收藏

页码：1571 / 1585

页数：15

相关论文

共 94 条

[81]

TAO ZF, 2006, 232 ACS NATL M SAN F

[82]

Tao Zhi-Fu, 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P377, DOI 10.2174/187152006777698132

[83]

Tasber E.S., 2007, WO, Patent No. 2007008502

[84]

TONG Y, 2006, 232 ACS NATL M SAN F

[85]

TONG Y, 2004, Patent No. 2004080973

[86]

TONG Y, 2004, Patent No. 20040259904

[87] Potentiation of cytotoxicity of topoisomerase I poison by concurrent and sequential treatment with the checkpoint inhibitor UCN-01 involves disparate mechanisms resulting in either p53-independent clonogenic suppression or p53-dependent mitotic catastrophe [J].

Tse, AN ;

Schwartz, GK .

CANCER RESEARCH, 2004, 64 (18) :6635-6644

[88] CHIR-124, a novel potent inhibitor of Chk1, potentiates the cytotoxicity of topoisomerase I poisons in vitro and in vivo [J].

Tse, Archie N. ;

Rendahl, Katherine G. ;

Sheikh, Tahir ;

Cheema, Haider ;

Aardalen, Kim ;

Embry, Millicent ;

Ma, Sylvia ;

Moler, Edward J. ;

Ni, Zhi Jie ;

de Menezes, Daniel E. Lopes ;

Hibner, Barbara ;

Gesner, Thomas G. ;

Schwartz, Gary K. .

CLINICAL CANCER RESEARCH, 2007, 13 (02) :591-602

[89]

WALMSLEY DL, 2006, Patent No. 2006134318

[90] 1-(5-Chloro-2-alkoxyphenyl)-3-(5-cyanopyrazi-2-yl)ureas as potent and selective inhibitors of Chk1 kinase: Synthesis, preliminary SAR, and biological activities [J].

Wang, GT ;

Li, GQ ;

Mantei, RA ;

Chen, ZH ;

Kovar, P ;

Gu, W ;

Xiao, Z ;

Zhang, HY ;

Sham, HL ;

Sowin, T ;

Rosenberg, SH ;

Lin, NH .

JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (09) :3118-3121

← 1 2 3 4 5 6 7 8 9 10 →